Evidence map›Paper›PMID 36274934›Full record

ArticleiScience2022

Link between glucose metabolism and epithelial-to-mesenchymal transition drives triple-negative breast cancer migratory heterogeneity.

Samantha C Schwager, Jenna A Mosier, Reethi S Padmanabhan, Addison White, Qinzhe Xing, Lauren A Hapach, Paul V Taufalele, Ismael Ortiz, Cynthia A Reinhart-King

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Samantha C SchwagerDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Jenna A MosierDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Reethi S PadmanabhanDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Addison WhiteDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Qinzhe XingDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Lauren A HapachNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Paul V TaufaleleDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Ismael OrtizDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Cynthia A Reinhart-KingDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212 USA.
Vanderbilt University · USCornell University · US

Funding

Molecular Determinants of Confined MigrationR01GM131178 · NIGMS · VANDERBILT UNIVERSITY · PI MARKOV, DMITRY · 2019 to 2022
$1.5M
NIGMS NIH HHS R01 GM131178
6 · The paper itself

Abstract

Intracellular and environmental cues result in heterogeneous cancer cell populations with different metabolic and migratory behaviors. Although glucose metabolism and epithelial-to-mesenchymal transition have previously been linked, we aim to understand how this relationship fuels cancer cell migration. We show that while glycolysis drives single-cell migration in confining microtracks, fast and slow cells display different migratory sensitivities to glycolysis and oxidative phosphorylation inhibition. Phenotypic sorting of highly and weakly migratory subpopulations (MDA

Indexed as

Biological sciencescancerhuman metabolismphysiology

Identifiers

PMID36274934
PMCPMC9579510
OpenAlexW4298395411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.